GDRX logo

GoodRx Holdings (GDRX) Depreciation and amortization

annual D&A:

$69.54M-$38.13M(-35.41%)
December 31, 2024

Summary

  • As of today (June 2, 2025), GDRX annual depreciation & amortization is $69.54 million, with the most recent change of -$38.13 million (-35.41%) on December 31, 2024.
  • During the last 3 years, GDRX annual D&A has risen by +$35.00 million (+101.33%).
  • GDRX annual D&A is now -35.41% below its all-time high of $107.67 million, reached on December 31, 2023.

Performance

GDRX Depreciation and amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGDRXincome statement metrics

quarterly D&A:

$20.91M+$1.82M(+9.51%)
March 31, 2025

Summary

  • As of today (June 2, 2025), GDRX quarterly depreciation & amortization is $20.91 million, with the most recent change of +$1.82 million (+9.51%) on March 31, 2025.
  • Over the past year, GDRX quarterly D&A has increased by +$4.97 million (+31.18%).
  • GDRX quarterly D&A is now -52.05% below its all-time high of $43.61 million, reached on December 31, 2023.

Performance

GDRX quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGDRXincome statement metrics

TTM D&A:

$74.51M+$4.97M(+7.15%)
March 31, 2025

Summary

  • As of today (June 2, 2025), GDRX TTM depreciation & amortization is $74.51 million, with the most recent change of +$4.97 million (+7.15%) on March 31, 2025.
  • Over the past year, GDRX TTM D&A has dropped by -$34.16 million (-31.44%).
  • GDRX TTM D&A is now -31.98% below its all-time high of $109.54 million, reached on June 30, 2024.

Performance

GDRX TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGDRXincome statement metrics

GDRX Depreciation and amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-35.4%+31.2%-31.4%
3 y3 years+101.3%+83.9%+83.7%
5 y5 years+412.3%+381.3%+1614.8%

GDRX Depreciation and amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-35.4%+101.3%-52.0%+83.9%-32.0%+83.7%
5 y5-year-35.4%+412.3%-52.0%+381.3%-32.0%+1614.8%
alltimeall time-35.4%+609.1%-52.0%+381.3%-32.0%+1614.8%

GDRX Depreciation and amortization History

DateAnnualQuarterlyTTM
Mar 2025
-
$20.91M(+9.5%)
$74.51M(+7.1%)
Dec 2024
$69.54M(-35.4%)
$19.10M(+8.9%)
$69.54M(-26.1%)
Sep 2024
-
$17.54M(+3.4%)
$94.05M(-14.1%)
Jun 2024
-
$16.96M(+6.4%)
$109.54M(+0.8%)
Mar 2024
-
$15.94M(-63.4%)
$108.67M(+0.9%)
Dec 2023
$107.67M(+98.7%)
$43.61M(+32.0%)
$107.67M(+35.3%)
Sep 2023
-
$33.02M(+105.2%)
$79.59M(+31.5%)
Jun 2023
-
$16.10M(+7.8%)
$60.52M(+4.8%)
Mar 2023
-
$14.94M(-3.8%)
$57.74M(+6.6%)
Dec 2022
$54.18M
$15.53M(+11.3%)
$54.18M(+9.9%)
Sep 2022
-
$13.95M(+4.8%)
$49.29M(+8.3%)
DateAnnualQuarterlyTTM
Jun 2022
-
$13.32M(+17.1%)
$45.50M(+12.2%)
Mar 2022
-
$11.37M(+6.8%)
$40.55M(+17.4%)
Dec 2021
$34.54M(+87.4%)
$10.65M(+4.8%)
$34.54M(+22.1%)
Sep 2021
-
$10.16M(+21.4%)
$28.30M(+21.5%)
Jun 2021
-
$8.37M(+56.1%)
$23.29M(+19.8%)
Mar 2021
-
$5.36M(+21.7%)
$19.45M(+5.5%)
Dec 2020
$18.43M(+35.8%)
$4.40M(-14.7%)
$18.43M(+31.4%)
Sep 2020
-
$5.16M(+14.1%)
$14.03M(+58.2%)
Jun 2020
-
$4.52M(+4.1%)
$8.87M(+104.1%)
Mar 2020
-
$4.34M
$4.34M
Dec 2019
$13.57M(+38.4%)
-
-
Dec 2018
$9.81M
-
-

FAQ

  • What is GoodRx Holdings annual depreciation & amortization?
  • What is the all time high annual D&A for GoodRx Holdings?
  • What is GoodRx Holdings annual D&A year-on-year change?
  • What is GoodRx Holdings quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for GoodRx Holdings?
  • What is GoodRx Holdings quarterly D&A year-on-year change?
  • What is GoodRx Holdings TTM depreciation & amortization?
  • What is the all time high TTM D&A for GoodRx Holdings?
  • What is GoodRx Holdings TTM D&A year-on-year change?

What is GoodRx Holdings annual depreciation & amortization?

The current annual D&A of GDRX is $69.54M

What is the all time high annual D&A for GoodRx Holdings?

GoodRx Holdings all-time high annual depreciation & amortization is $107.67M

What is GoodRx Holdings annual D&A year-on-year change?

Over the past year, GDRX annual depreciation & amortization has changed by -$38.13M (-35.41%)

What is GoodRx Holdings quarterly depreciation & amortization?

The current quarterly D&A of GDRX is $20.91M

What is the all time high quarterly D&A for GoodRx Holdings?

GoodRx Holdings all-time high quarterly depreciation & amortization is $43.61M

What is GoodRx Holdings quarterly D&A year-on-year change?

Over the past year, GDRX quarterly depreciation & amortization has changed by +$4.97M (+31.18%)

What is GoodRx Holdings TTM depreciation & amortization?

The current TTM D&A of GDRX is $74.51M

What is the all time high TTM D&A for GoodRx Holdings?

GoodRx Holdings all-time high TTM depreciation & amortization is $109.54M

What is GoodRx Holdings TTM D&A year-on-year change?

Over the past year, GDRX TTM depreciation & amortization has changed by -$34.16M (-31.44%)
On this page